The Eagle Country, Minnesota.
Steam rose from Freeman's head as he lay in the jacuzzi with his eyes closed, finding some relief from the fatigue in his muscles.
As a professional athlete, he needs to undergo high-intensity training every day to maintain his physical fitness.
He soaked in the bath for a full half hour before getting up, wrapping himself tightly in his bathrobe, and returning to the living room.
Just then, the phone rang. After answering it, he barely spoke a few words before his face lit up with excitement.
"What? You got me a trial qualification for Oral Insulin?"
"Great, I'll head over tomorrow morning."
After hanging up the phone, Freeman was immediately thrilled.
My private doctor just called and said that Sanqing Group's Oral Insulin has finally started clinical trials in the Eagle Country. This new drug has outstanding efficacy, is easy to take, and is very suitable for athletes like him.
From now on, you will only need to take oral tablets daily to achieve the effect of insulin intake and blood sugar control.
No more need to stick an insulin pump on your belly.
Thinking of this, Freeman looked at the insulin pump on his body with some disdain.
Carrying this thing around all the time is too inconvenient for high-intensity exercise.
Although he was already used to it, it would be best to take it off.
The thought of being able to use Oral Insulin tomorrow brought a sense of relief to his heart, and he walked briskly into the bedroom.
This thing probably won't last much longer.
At the age of 21, just as he became a skier, he was diagnosed with Type I Diabetes.
That was the first time he had ever heard of the disease. When the doctor advised him to end his skiing career and find a new job, it was like a bolt from the blue, leaving him extremely depressed.
Fortunately, Freeman has a resilient character and did not give in to fate. Instead, he cooperated with the doctor to actively treat the disease, strictly followed the doctor's instructions to inject insulin, adjusted his diet according to his exercise training, monitored his blood sugar, and underwent regular screening for complications every year.
Through a series of strict measures, he finally managed to control his illness, maintain a high level of athletic performance, and reverse his fate.
Just two years after being diagnosed with Diabetes, he won a gold medal in skiing at the Winter Olympics.
To date, he has won multiple gold medals as a Diabetes athlete and is renowned worldwide.
People see his achievements and praise him highly, but no one knows that he checks his blood sugar five or six times a day, injects insulin every day, and wears an insulin pump 24 hours a day.
He had always longed for Diabetes to be completely cured.
If all else fails, at least he can Oral Insulin so he doesn't have to wear that pig-tail-like insulin pump anymore.
Fortunately, technological advancements finally brought him this day.
Perhaps the day when Diabetes is completely cured is not far away.
Freeman has never been so confident about this as he is today.
The next day, he went to the designated medical facility to begin the drug trial.
After experiencing it, I was both surprised and delighted.
This Oral Insulin worked just as he had imagined.
No, it's even more effective.
As long as you calculate the dosage correctly and take the medication on time before each meal, your blood sugar will remain stable.
No more enduring the sudden alarm of the insulin pump, no more constantly monitoring the insulin pump rate, and no more worrying about the insulin infusion being interrupted.
Like a bird that has regained its wings and is soaring in the sky, he once again experienced the feeling of freedom.
There are many people like Freeman who participate in drug trials.
Having experienced the benefits of Oral Insulin during drug trials, they naturally developed a strong aversion to injectable insulin.
When the trial ended, everyone felt lost and somewhat unable to accept it, wishing they could immediately buy the new drug at the pharmacy.
Unfortunately, Phase III Clinical Trial require a large number of samples and a long period of clinical observation, so they cannot be quickly brought to market.
Especially for medications for chronic diseases that require long-term use, where the patient is not in immediate danger of death and there are similar medications available on the market, the requirements are more stringent and the treatment time is longer.
Even with the breakthrough fast-track application model, it still takes six months to a year to verify the drug's safety over a wide range of applications.
Even after a company goes public, it must continue to undergo Phase IV trials for validation. If any problems arise, it could be forced to withdraw from the market at any time.
Such a complete set of clinical trials costs a very high amount of money, often tens of millions of US dollars. Apart from pharmaceutical giants, there are really very few pharmaceutical companies that can afford to burn through such funds.
This is why the successful development of a new drug is only the first step; reaching Phase III is only half the battle won.
Only when it goes public and sells well can it be considered a complete success.
Even if most laboratories and small businesses successfully develop a drug, they cannot afford the subsequent clinical trial costs. They can only ensure that the drug can be developed in cooperation with large pharmaceutical companies to ensure that it can be launched on the market.
*******
Just as the reputation of Oral Insulin was slowly gaining traction across the ocean.
Phase III Clinical Trial in China are also progressing simultaneously.
Wei Kang was very satisfied with the progress of the project.
"Next, we just need to proceed step by step. Once the Phase III Clinical Trial is completed, the earliest it will be on the market will be next year."
"There's no rush, we can take our time."
The farce surrounding insulin in the Eagle Country naturally reached China as well, and was eagerly broadcast by various media outlets. Everyone watched it like a thrilling drama full of twists and turns, thoroughly enjoying it.
Wei Kang had naturally paid attention to this matter and found it both laughable and absurd.
"The Eagle Country is indeed a free country; anything is possible, no matter how absurd. Fortunately, the final result was not bad."
"At least Eli Lilly the first to back down, and insulin prices dropped significantly, which greatly reduced the burden on Diabetes and allowed them to live a better life."
"Eli Lilly truly lives up to its reputation as a pharmaceutical giant; their reaction was incredibly swift. These old guys who are still alive and well after more than a hundred years are indeed cunning old foxes; none of them are easy to deal with."
"I just don't know if other insulin manufacturers will follow suit. If they insist on not lowering prices, the market will probably be completely taken over by Eli Lilly. I don't think they're that stupid. Sooner or later they'll compromise and lower prices together."
"The insulin market structure is already established. At least overseas, Oral Insulin will dominate the mid-to-high-end market, while the price of injectable insulin will drop significantly, making it a daily medication that even the poor can afford. This is a huge benefit for Diabetes."
"This is roughly what is meant by technology driving social development."
"If the three giants can complete their transformation and focus on Blood-Sugar-Lowering Drug, it's hard to say whether it's a blessing or a curse."
Wei Kang knew very well that Eli Lilly's confidence in lowering prices stemmed from its GLP-1 Blood-Sugar-Lowering Drug.
Admitting defeat when outmatched and shifting focus to other areas, rather than putting all their eggs in one basket, is a fine tradition of these established pharmaceutical giants.
Diabetes is a complex chronic disease, and new treatment ideas and solutions are constantly emerging. As long as they are effective, they can sell very well.
Even hereditary Diabetes is caused by multiple gene mutations, not by a single gene. Furthermore, what is inherited is not the disease itself, but a susceptibility to Diabetes. Certain environmental factors must be present for Diabetes to develop.
Generally speaking, whether insulin therapy is needed depends on the degree of insulin deficiency.
For patients with Type I Diabetes, insulin therapy is essential, but for many patients with Type II Diabetes, insulin is just an enhancement of treatment. They are not so dependent on insulin and can improve their condition by taking blood Blood-Sugar-Lowering Drug such as GLP-1.
After more than a century of development, Blood-Sugar-Lowering Drug have become diverse and abundant, presenting a flourishing landscape that no single pharmaceutical company can monopolize.
Three Purities currently has some Blood-Sugar-Lowering Drug, but these are only one or two areas, and not the most popular category.
However, Wei Kang does not intend to join the crowded new track of GLP-1 receptor agonists.
As a technology-driven pharmaceutical group, the choice of R&D direction should naturally be in line with its own technological field. It cannot be like investors who rush into whatever hot track they see.
The best long-term strategy is to first solidify the foundation of the Type I Diabetes, and then leverage our strengths to cultivate expertise in this field.
Wei Kang had long planned for this; his ultimate goal was to completely cure Diabetes.
The reason why Diabetes is incurable is closely related to the damage to Islet Cells, insulin resistance, and insulin secretion.
Ultimately, however, it boils down to the problem of damaged Islet Cells.
Islet Cells are highly differentiated cells that cannot self-replicate. Once damaged, they cannot regenerate and therefore cannot secrete insulin normally.
Other tissue cells, such as hepatocytes, have a low degree of differentiation, can continuously replicate, and have a strong regenerative capacity.
When the liver is damaged, it can repair itself, so many liver problems can be restored to normal through medication and maintenance. However, Islet Cells are powerless to do so.
Many people with Type II Diabetes can recover their health by taking medication and controlling their diet if they only have problems with insulin resistance and secretion.
However, if Islet Cells are damaged, even if blood sugar is well controlled, lifelong medication or even continuous insulin injections may be necessary.
Needless to say, people with Type I Diabetes have already damaged most of their Islet Cells by the time the disease develops, and can only rely on insulin injections to maintain their lives for the rest of their lives.
Since Islet Cells cannot regenerate, the only solution after they are damaged is transplantation.
In fact, Islet Cells transplantation has always been a cutting-edge research topic in medicine.
Not only have there been many successful Animal Experiment, but there have also been some successful cases in clinical trials.
There were hardly any obvious side effects. Most patients experienced relief from their condition, significantly reduced insulin injections, and some even returned to normal life after transplantation, no longer needing medication or insulin injections.
The only problem is that Islet Cells mainly come from donated pancreas, making the source very limited.
The effects are also very limited. All patients who undergo cell transplantation will experience Immune Rejection after a few months, or at most one to two years, and will revert to their pre-transplant state. The effects cannot be maintained permanently.
This technology requires intermittent and continuous transplantation of Islet Cells to patients, and it is not yet mature in general. Moreover, the transplantation surgery is very expensive and cannot be used to treat large numbers of Diabetes patients.
These problems are not too big for Wei Kang.
Because he plans to use a new method, namely pancreatic islet stem cell transplantation, for treatment.
Human pluripotent stem cells can differentiate into Islet Cells. As long as these differentiated Islet Cells are extracted, cultured in vitro, and transplanted into the human body, they can secrete insulin normally and completely cure Diabetes.
However, there are still many obstacles to rebuilding pancreatic islet function using stem cell technology. The techniques for extracting and isolating pancreatic islet stem cells and inducing the maturation of insulin-secreting cells need further improvement.
There is a lack of universally accepted methods for fully differentiating stem cells into Islet Cells.
In some studies, pancreatic islet stem cells transformed from embryonic stem cells transformed into teratomas when used to treat Diabetes mice, resulting in the loss of their hypoglycemic effect and raising significant safety concerns.
Three Purities has already developed the technology to differentiate stem cells into Artificial Blood, marking a breakthrough in stem cell research.
This gave Wei Kang enough confidence. He believed that as long as he conducted in-depth research in this area, he would eventually be able to differentiate pluripotent stem cells into Islet Cells, and produce Islet Cells like blood for clinical use.
On that day, the treatment of Diabetes will undergo a tremendous transformation, and every patient will benefit from it.
Diabetes, a modern disease of affluence that has emerged due to an abundance of food, now has the hope of a complete cure.
"The road ahead is long and arduous, but I will persevere in my search. How difficult it is to truly cure a disease."
Wei Kang sighed deeply and said, "We, as medical professionals, can only burn our lives and throw ourselves into it without hesitation."
As he developed more and more drugs, he felt the burden on his shoulders growing heavier and heavier.
If he had started as the owner of a small pharmaceutical company, only wanting to develop a blockbuster drug that would be a money-making machine, so that he would never have to worry about money for the rest of his life.
As for how medical technology develops or how human science and technology advance, that's none of his business.
When the sky falls, there are always tall people to hold it up; in the field of technology, scientists are always at the forefront, blazing trails and thorns.
Now that Three Purities has reached this point, as the beacon of human medicine, he has become the tallest and the one at the forefront.
Many breakthroughs in new technologies and expansions into new fields require his leadership and are inseparable from the efforts of all Three Purities.
His mindset has also changed dramatically; money is no longer what he values most.
Instead, he developed a sense of social responsibility, which has become his life motto.
Three Purities must be responsible to the motherland, to society, and even more so to the millions of patients.
If you want to wear the crown, you must bear its weight.
If the leader in an industry cannot be proactive and innovative, what vitality does that industry have?
In the past, China's pharmaceutical industry was just coasting along, relentlessly engaging in internal strife and fighting tooth and nail for the generic drug market.
It has never produced any original drugs in any cutting-edge field, and all of its revenue is invested in sales, making the research and development department almost superfluous.
Before the rise of the Three Purities, many industries already had the presence of China giants, who had become among the top in the world.
The pharmaceutical industry remains stagnant, showing no signs of improvement, and doesn't even have a single original drug that sells globally.
Without Three Purities, it's hard to imagine how this industry could have gotten to where it is today.
Wei Kang sighed for a moment, then composed himself, clicked on the computer, and created a new project folder.
<Islet Stem Cell Transplant Project>
Then the project personnel were assigned.
After finishing those tasks, he began to check on the progress of other projects.
"Great, several new drugs are progressing smoothly and have entered Phase III."
"The Artificial Heart project has brought in an existing team, completed the personnel integration and technology integration, and has begun research and development."
"With the strong support of external partners, the Bionic Microneedle project has successfully developed nano-alloy materials and is currently manufacturing the first batch of samples."
As he looked at it, his eyes suddenly lit up.
"Great, the Artificial Blood Vessel sample is ready."